Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 893

1.

Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment.

Ottensmeier H, Schlegel PG, Eyrich M, Wolff JE, Juhnke BO, von Hoff K, Frahsek S, Schmidt R, Faldum A, Fleischhack G, von Bueren A, Friedrich C, Resch A, Warmuth-Metz M, Krauss J, Kortmann RD, Bode U, Kühl J, Rutkowski S.

PLoS One. 2020 Jan 23;15(1):e0227693. doi: 10.1371/journal.pone.0227693. eCollection 2020.

2.

Implementation of New Technology in Patients with Chronic Deep Brain Stimulation: Switching from Non-Rechargeable Constant Voltage to Rechargeable Constant Current Stimulation.

Wolf ME, Klockziem M, Majewski O, Schulte DM, Krauss JK, Blahak C.

Stereotact Funct Neurosurg. 2020 Jan 16:1-7. doi: 10.1159/000505076. [Epub ahead of print]

PMID:
31945765
3.

Patient Engagement With an Automated Telephone Symptom Management Intervention: Predictors and Outcomes.

Sikorskii A, Given CW, Given BA, Banik A, Krauss JC.

Ann Behav Med. 2020 Jan 11. pii: kaz067. doi: 10.1093/abm/kaz067. [Epub ahead of print]

PMID:
31925414
4.

Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma.

Adeberg S, Windisch P, Ehret F, Baur M, Akbaba S, Held T, Bernhardt D, Haefner MF, Krauss J, Kargus S, Freudlsperger C, Plinkert P, Flechtenmacher C, Herfarth K, Debus J, Rieken S.

Front Oncol. 2019 Dec 20;9:1420. doi: 10.3389/fonc.2019.01420. eCollection 2019.

5.

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.

Doebele RC, Drilon A, Paz-Ares L, Siena S, Shaw AT, Farago AF, Blakely CM, Seto T, Cho BC, Tosi D, Besse B, Chawla SP, Bazhenova L, Krauss JC, Chae YK, Barve M, Garrido-Laguna I, Liu SV, Conkling P, John T, Fakih M, Sigal D, Loong HH, Buchschacher GL Jr, Garrido P, Nieva J, Steuer C, Overbeck TR, Bowles DW, Fox E, Riehl T, Chow-Maneval E, Simmons B, Cui N, Johnson A, Eng S, Wilson TR, Demetri GD; trial investigators.

Lancet Oncol. 2019 Dec 11. pii: S1470-2045(19)30691-6. doi: 10.1016/S1470-2045(19)30691-6. [Epub ahead of print]

PMID:
31838007
6.

Position-Dependent Dysfunction of Deep Brain Stimulation in Tourette Syndrome: Diagnostic Clues.

Wolf ME, Majewski O, Müller-Vahl KR, Blahak C, Schulte DM, Krauss JK.

Tremor Other Hyperkinet Mov (N Y). 2019 Oct 23;9. doi: 10.7916/tohm.v0.713. eCollection 2019.

7.

Staphylococcus aureus Infects Osteoclasts and Replicates Intracellularly.

Krauss JL, Roper PM, Ballard A, Shih CC, Fitzpatrick JAJ, Cassat JE, Ng PY, Pavlos NJ, Veis DJ.

mBio. 2019 Oct 15;10(5). pii: e02447-19. doi: 10.1128/mBio.02447-19.

8.

Deep brain stimulation of the thalamic centromedian-parafascicular nucleus improves behavioural and neuronal traits in a rat model of Tourette.

Elle T, Alam M, Voigt C, Krauss JK, John N, Schwabe K.

Behav Brain Res. 2020 Jan 27;378:112251. doi: 10.1016/j.bbr.2019.112251. Epub 2019 Oct 12.

PMID:
31614188
9.

Favorable prognosis in pediatric brainstem low-grade glioma: Report from the German SIOP-LGG 2004 cohort.

Holzapfel J, Kandels D, Schmidt R, Pietsch T, Warmuth-Metz M, Bison B, Krauss J, Kortmann RD, Timmermann B, Thomale UW, Albert MH, Hernáiz Driever P, Witt O, Gnekow AK.

Int J Cancer. 2019 Oct 15. doi: 10.1002/ijc.32734. [Epub ahead of print]

PMID:
31613986
10.

Characterization of two new degradation products of atorvastatin calcium formed upon treatment with strong acids.

Krauß J, Klimt M, Luber M, Mayer P, Bracher F.

Beilstein J Org Chem. 2019 Sep 2;15:2085-2091. doi: 10.3762/bjoc.15.206. eCollection 2019.

11.

Neuroanatomical correlates of mobility: Sensory brain centres are bigger in winged than in wingless parthenogenetic pea aphid females.

Gadenne C, Groh C, Grübel K, Joschinski J, Krauss J, Krieger J, Rössler W, Anton S.

Arthropod Struct Dev. 2019 Sep;52:100883. doi: 10.1016/j.asd.2019.100883. Epub 2019 Sep 27.

PMID:
31568972
12.

Cerebello-striatal interaction mediates effects of subthalamic nucleus deep brain stimulation in Parkinson's disease.

Hanssen H, Steinhardt J, Münchau A, Al-Zubaidi A, Tzvi E, Heldmann M, Schramm P, Neumann A, Rasche D, Saryyeva A, Voges J, Galazky I, Büntjen L, Heinze HJ, Krauss JK, Tronnier V, Münte TF, Brüggemann N.

Parkinsonism Relat Disord. 2019 Oct;67:99-104. doi: 10.1016/j.parkreldis.2019.09.003. Epub 2019 Sep 3.

PMID:
31494048
13.

Pallidal low-frequency activity in dystonia after cessation of long-term deep brain stimulation.

Scheller U, Lofredi R, van Wijk BCM, Saryyeva A, Krauss JK, Schneider GH, Kroneberg D, Krause P, Neumann WJ, Kühn AA.

Mov Disord. 2019 Nov;34(11):1734-1739. doi: 10.1002/mds.27838. Epub 2019 Sep 4.

PMID:
31483903
14.

Detection of bacterial DNA on neurostimulation systems in patients without overt infection.

Hong B, Winkel A, Stumpp N, Abdallat M, Saryyeva A, Runge J, Stiesch M, Krauss JK.

Clin Neurol Neurosurg. 2019 Sep;184:105399. doi: 10.1016/j.clineuro.2019.105399. Epub 2019 Jun 24.

PMID:
31302380
15.

Infection Rates and Alkaloid Patterns of Different Grass Species with Systemic Epichloë Endophytes.

Vikuk V, Young CA, Lee ST, Nagabhyru P, Krischke M, Mueller MJ, Krauss J.

Appl Environ Microbiol. 2019 Aug 14;85(17). pii: e00465-19. doi: 10.1128/AEM.00465-19. Print 2019 Sep 1.

PMID:
31227553
16.

Standardized nutritional supply versus individual nutritional assessment: Impact on weight changes, complications and functional outcome from neurological early rehabilitation.

Schmidt SB, Boltzmann M, Krauss JK, Stangel M, Gutenbrunner C, Rollnik JD.

Clin Nutr. 2019 May 16. pii: S0261-5614(19)30224-9. doi: 10.1016/j.clnu.2019.05.013. [Epub ahead of print]

17.

Potential mediators of improvement in painful chemotherapy-induced peripheral neuropathy via a web-based cognitive behavioural intervention.

Knoerl R, Barton DL, Holden JE, Krauss JC, LaVasseur B, Smith EML.

Can Oncol Nurs J. 2018 Jul 1;28(3):178-183. doi: 10.5737/23688076283178183. eCollection 2018 Summer.

18.

Médiateurs potentiels d’amélioration de la neuropathie périphérique chimio-induite douloureuse par une intervention cognitivocomportementale en ligne.

Knoerl R, Barton DL, Holden JE, Krauss JC, LaVasseur B, Smith EML.

Can Oncol Nurs J. 2018 Jul 1;28(3):184-190. doi: 10.5737/23688076283184190. eCollection 2018 Summer. French. No abstract available.

PMID:
31148827
Free PMC Article
19.

Tumour-treating fields (TTFields): Investigations on the mechanism of action by electromagnetic exposure of cells in telophase/cytokinesis.

Berkelmann L, Bader A, Meshksar S, Dierks A, Hatipoglu Majernik G, Krauss JK, Schwabe K, Manteuffel D, Ngezahayo A.

Sci Rep. 2019 May 14;9(1):7362. doi: 10.1038/s41598-019-43621-9.

20.

Adverse events associated with deep brain stimulation in patients with childhood-onset dystonia.

Koy A, Bockhorn N, Kühn AA, Schneider GH, Krause P, Lauritsch K, Witt K, Paschen S, Deuschl G, Krauss JK, Saryyeva A, Runge J, Borggraefe I, Mehrkens JH, Horn A, Vesper J, Schnitzler A, Siegert S, Freilinger M, Eckenweiler M, Coenen VA, Tadic V, Voges J, Pauls KAM, Wirths J, Timmermann L, Hellmich M; GEPESTIM consortium.

Brain Stimul. 2019 Sep - Oct;12(5):1111-1120. doi: 10.1016/j.brs.2019.04.003. Epub 2019 Apr 13.

PMID:
31031208
21.

Glial tumors and deep brain stimulation: An increasingly recognized association?

Akçakaya MO, Saryyeva A, Heissler HE, Hermann EJ, Krauss JK.

J Clin Neurosci. 2019 Jun;64:1-3. doi: 10.1016/j.jocn.2019.04.008. Epub 2019 Apr 24.

PMID:
31029525
22.

Neurobiological Mechanisms of Metacognitive Therapy - An Experimental Paradigm.

Winter L, Alam M, Heissler HE, Saryyeva A, Milakara D, Jin X, Heitland I, Schwabe K, Krauss JK, Kahl KG.

Front Psychol. 2019 Apr 4;10:660. doi: 10.3389/fpsyg.2019.00660. eCollection 2019.

23.

Long-term impairment of social behavior, vocalizations and motor activity induced by bilateral lesions of the fastigial nucleus in juvenile rats.

Al-Afif S, Krauss JK, Helms F, Angelov S, John N, Schwabe K, Hermann EJ.

Brain Struct Funct. 2019 Jun;224(5):1739-1751. doi: 10.1007/s00429-019-01871-3. Epub 2019 Apr 12.

PMID:
30980139
24.

The interplay of landscape composition and configuration: new pathways to manage functional biodiversity and agroecosystem services across Europe.

Martin EA, Dainese M, Clough Y, Báldi A, Bommarco R, Gagic V, Garratt MPD, Holzschuh A, Kleijn D, Kovács-Hostyánszki A, Marini L, Potts SG, Smith HG, Al Hassan D, Albrecht M, Andersson GKS, Asís JD, Aviron S, Balzan MV, Baños-Picón L, Bartomeus I, Batáry P, Burel F, Caballero-López B, Concepción ED, Coudrain V, Dänhardt J, Diaz M, Diekötter T, Dormann CF, Duflot R, Entling MH, Farwig N, Fischer C, Frank T, Garibaldi LA, Hermann J, Herzog F, Inclán D, Jacot K, Jauker F, Jeanneret P, Kaiser M, Krauss J, Le Féon V, Marshall J, Moonen AC, Moreno G, Riedinger V, Rundlöf M, Rusch A, Scheper J, Schneider G, Schüepp C, Stutz S, Sutter L, Tamburini G, Thies C, Tormos J, Tscharntke T, Tschumi M, Uzman D, Wagner C, Zubair-Anjum M, Steffan-Dewenter I.

Ecol Lett. 2019 Jul;22(7):1083-1094. doi: 10.1111/ele.13265. Epub 2019 Apr 7.

25.

Implementation of the Current Dystonia Classification from 2013 to 2018.

Sasikumar S, Albanese A, Krauss JK, Fasano A.

Mov Disord Clin Pract. 2019 Mar 1;6(3):250-253. doi: 10.1002/mdc3.12736. eCollection 2019 Mar.

PMID:
30949557
26.

Stimulation of the globus pallidus internus in the treatment of Parkinson's disease: Long-term results of a monocentric cohort.

Lachenmayer ML, Bettschen C, Bernasconi C, Petermann K, Debove I, Muellner J, Michelis JP, Burgunder JM, Krauss JK, Oertel MF, Pollo C, Kaelin-Lang A, Schüpbach M.

Parkinsonism Relat Disord. 2019 Jul;64:118-123. doi: 10.1016/j.parkreldis.2019.03.009. Epub 2019 Mar 16.

PMID:
30935828
27.

First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma.

Massard C, Soria JC, Krauss J, Gordon M, Lockhart AC, Rasmussen E, Upreti VV, Patel S, Ngarmchamnanrith G, Henary H.

Cancer Chemother Pharmacol. 2019 Jun;83(6):1057-1063. doi: 10.1007/s00280-019-03796-4. Epub 2019 Mar 26.

PMID:
30915497
28.

The prevalence of antiseptic tolerance genes among staphylococci and enterococci in a pediatric population.

Sommer LM, Krauss JL, Hultén KG, Dunn JJ, Kaplan SL, McNeil JC.

Infect Control Hosp Epidemiol. 2019 Mar;40(3):333-340. doi: 10.1017/ice.2019.3.

PMID:
30887943
29.

"Warning" to postoperative complications when using hemostatic agents!

Al-Afif S, Krauss JK.

Acta Neurochir (Wien). 2019 May;161(5):873. doi: 10.1007/s00701-019-03864-x. Epub 2019 Mar 15. No abstract available.

PMID:
30877473
30.

Resveratrol, lunularin and dihydroresveratrol do not act as caloric restriction mimetics when administered intraperitoneally in mice.

Pallauf K, Chin D, Günther I, Birringer M, Lüersen K, Schultheiß G, Vieten S, Krauß J, Bracher F, Danylec N, Soukup ST, Kulling SE, Rimbach G.

Sci Rep. 2019 Mar 14;9(1):4445. doi: 10.1038/s41598-019-41050-2.

31.

Probabilistic mapping of the antidystonic effect of pallidal neurostimulation: a multicentre imaging study.

Reich MM, Horn A, Lange F, Roothans J, Paschen S, Runge J, Wodarg F, Pozzi NG, Witt K, Nickl RC, Soussand L, Ewert S, Maltese V, Wittstock M, Schneider GH, Coenen V, Mahlknecht P, Poewe W, Eisner W, Helmers AK, Matthies C, Sturm V, Isaias IU, Krauss JK, Kühn AA, Deuschl G, Volkmann J.

Brain. 2019 May 1;142(5):1386-1398. doi: 10.1093/brain/awz046.

PMID:
30851091
32.

Saliva molecular inflammatory profiling in female migraine patients responsive to adjunctive cervical non-invasive vagus nerve stimulation: the MOXY Study.

Boström A, Scheele D, Stoffel-Wagner B, Hönig F, Chaudhry SR, Muhammad S, Hurlemann R, Krauss JK, Lendvai IS, Chakravarthy KV, Kinfe TM.

J Transl Med. 2019 Feb 22;17(1):53. doi: 10.1186/s12967-019-1801-y.

33.

Development of evidence-based quality indicators for deep brain stimulation in patients with Parkinson's disease and first year experience of implementation of a nation-wide registry.

Haas K, Stangl S, Steigerwald F, Matthies C, Gruber D, Kühn AA, Krauss JK, Sixel-Döring F, von Eckardstein K, Deuschl G, Classen J, Winkler D, Voges J, Galazky I, Oertel W, Ceballos-Baumann AO, Lange M, Gharabaghi A, Weiss DT, Volkmann J, Heuschmann PU.

Parkinsonism Relat Disord. 2019 Mar;60:3-9. doi: 10.1016/j.parkreldis.2019.01.016. Epub 2019 Feb 5.

PMID:
30772278
34.

The Origins of Human Functional Stereotaxis: A Reappraisal.

Rzesnitzek L, Hariz M, Krauss JK.

Stereotact Funct Neurosurg. 2019;97(1):49-54. doi: 10.1159/000496157. Epub 2019 Feb 13.

35.

Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients.

Stock S, Übelhart R, Schubert ML, Fan F, He B, Hoffmann JM, Wang L, Wang S, Gong W, Neuber B, Hückelhoven-Krauss A, Gern U, Christ C, Hexel M, Schmitt A, Schmidt P, Krauss J, Jäger D, Müller-Tidow C, Dreger P, Schmitt M, Sellner L.

Int J Cancer. 2019 Sep 1;145(5):1312-1324. doi: 10.1002/ijc.32201. Epub 2019 Feb 28.

PMID:
30737788
36.

Deep brain stimulation for dystonia-choreoathetosis in cerebral palsy: Pallidal versus thalamic stimulation.

Wolf ME, Blahak C, Saryyeva A, Schrader C, Krauss JK.

Parkinsonism Relat Disord. 2019 Jun;63:209-212. doi: 10.1016/j.parkreldis.2019.01.029. Epub 2019 Jan 30.

PMID:
30718219
37.

Deep brain stimulation: current challenges and future directions.

Lozano AM, Lipsman N, Bergman H, Brown P, Chabardes S, Chang JW, Matthews K, McIntyre CC, Schlaepfer TE, Schulder M, Temel Y, Volkmann J, Krauss JK.

Nat Rev Neurol. 2019 Mar;15(3):148-160. doi: 10.1038/s41582-018-0128-2. Review.

38.

Pilot Study of Personalized Video Visit Summaries for Patients With Cancer.

Krauss JC, Sahai V, Kirch M, Simeone DM, An L.

JCO Clin Cancer Inform. 2018 Dec;2:1-8. doi: 10.1200/CCI.17.00086.

39.

The Role of Neurosurgery in the Treatment of Intracranial Tumor-Like Inflammatory Lesions.

Al-Afif S, Hatipoglu Majernik G, Al Krinawe Y, Esmaeilzadeh M, Hartmann C, Krauss JK.

World Neurosurg. 2018 Dec 13. pii: S1878-8750(18)32803-1. doi: 10.1016/j.wneu.2018.12.003. [Epub ahead of print]

PMID:
30554001
40.

Correction to: Intracranial foreign material granuloma after neurosurgical procedures.

Al-Afif S, Krauss JK.

Acta Neurochir (Wien). 2019 Jan;161(1):11. doi: 10.1007/s00701-018-3766-7.

PMID:
30547245
41.

Intracranial foreign material granuloma after neurosurgical procedures.

Al-Afif S, Krauss JK.

Acta Neurochir (Wien). 2019 Jan;161(1):15. doi: 10.1007/s00701-018-3751-1. Epub 2018 Nov 29. No abstract available. Erratum in: Acta Neurochir (Wien). 2018 Dec 13;:.

PMID:
30499034
42.

Multisegmental Lumbar Corporectomy and Transcorporal Fixation for Correction of Extreme Thoracolumbar Kyphosis in Myelomeningocele with Chronic Decubitus.

Kiepe F, Hermann EJ, Heissler HE, Henseler H, Vogt PM, Krauss JK.

Pediatr Neurosurg. 2019;54(2):116-120. doi: 10.1159/000494564. Epub 2018 Nov 27.

PMID:
30481786
43.

Pallidal beta bursts in Parkinson's disease and dystonia.

Lofredi R, Neumann WJ, Brücke C, Huebl J, Krauss JK, Schneider GH, Kühn AA.

Mov Disord. 2019 Mar;34(3):420-424. doi: 10.1002/mds.27524. Epub 2018 Nov 15.

PMID:
30440096
44.

Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical Trial.

Siu LL, Even C, Mesía R, Remenar E, Daste A, Delord JP, Krauss J, Saba NF, Nabell L, Ready NE, Braña I, Kotecki N, Zandberg DP, Gilbert J, Mehanna H, Bonomi M, Jarkowski A, Melillo G, Armstrong JM, Wildsmith S, Fayette J.

JAMA Oncol. 2019 Feb 1;5(2):195-203. doi: 10.1001/jamaoncol.2018.4628.

45.

Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination with a carbon ion boost for locally advanced tumors of the oro-, hypopharynx and larynx.

Hauswald H, Jensen AD, Krauss J, Haselmann R, Lossner K, Hartmann S, Windemuth-Kieselbach C, Münter MW, Debus J.

Clin Transl Radiat Oncol. 2018 Sep 21;13:64-73. doi: 10.1016/j.ctro.2018.09.005. eCollection 2018 Nov.

46.

Effects of depressive symptomatology on cancer-related symptoms during oral oncolytic treatment.

Decker V, Sikorskii A, Given CW, Given BA, Vachon E, Krauss JC.

Psychooncology. 2019 Jan;28(1):99-106. doi: 10.1002/pon.4916. Epub 2018 Oct 23.

PMID:
30311987
47.

Measuring Pressure: Introducing oBPM, the Optical Revolution for Blood Pressure Monitoring.

Sola J, Bertschi M, Krauss J.

IEEE Pulse. 2018 Sep-Oct;9(5):31-33. doi: 10.1109/MPUL.2018.2856960.

PMID:
30273141
48.

Pharmacokinetic Enhancers (Boosters)-Escort for Drugs against Degrading Enzymes and Beyond.

Krauß J, Bracher F.

Sci Pharm. 2018 Sep 27;86(4). pii: E43. doi: 10.3390/scipharm86040043. Review.

49.

Neurostimulation in tardive dystonia/dyskinesia: A delayed start, sham stimulation-controlled randomized trial.

Gruber D, Südmeyer M, Deuschl G, Falk D, Krauss JK, Mueller J, Müller JU, Poewe W, Schneider GH, Schrader C, Vesper J, Volkmann J, Winter C, Kupsch A, Schnitzler A; DBS study group for dystonia.

Brain Stimul. 2018 Nov - Dec;11(6):1368-1377. doi: 10.1016/j.brs.2018.08.006. Epub 2018 Sep 11.

PMID:
30249417
50.

Cerebellar glioblastoma: a clinical series with contemporary molecular analysis.

Hong B, Banan R, Christians A, Nakamura M, Lalk M, Lehmann U, Hartmann C, Krauss JK.

Acta Neurochir (Wien). 2018 Nov;160(11):2237-2248. doi: 10.1007/s00701-018-3673-y. Epub 2018 Sep 10.

PMID:
30203362

Supplemental Content

Loading ...
Support Center